Four-point hemostasis evaluation scale for bleeds of all severity in PERSEPT 1 and PERSEPT 2
| Hemostasis evaluation . | Description . | Treatment response . |
|---|---|---|
| None | No noticeable effect of treatment on the BE or worsening of patient’s condition Continuation of eptacog beta required | Unsatisfactory |
| Moderate | Some response was noticed (eg, pain decreased or bleeding signs improved) but bleeding continued Continuation of eptacog beta required | Unsatisfactory |
| Good | Symptoms of bleed (eg, swelling, tenderness, and decreased range of motion in the case of musculoskeletal hemorrhage) largely reduced but had not completely disappeared No continuation of eptacog beta required, given the improvement of the symptoms | Satisfactory |
| Excellent | Full pain relief and cessation of objective signs of bleeding No continuation of eptacog beta required | Satisfactory |
| Hemostasis evaluation . | Description . | Treatment response . |
|---|---|---|
| None | No noticeable effect of treatment on the BE or worsening of patient’s condition Continuation of eptacog beta required | Unsatisfactory |
| Moderate | Some response was noticed (eg, pain decreased or bleeding signs improved) but bleeding continued Continuation of eptacog beta required | Unsatisfactory |
| Good | Symptoms of bleed (eg, swelling, tenderness, and decreased range of motion in the case of musculoskeletal hemorrhage) largely reduced but had not completely disappeared No continuation of eptacog beta required, given the improvement of the symptoms | Satisfactory |
| Excellent | Full pain relief and cessation of objective signs of bleeding No continuation of eptacog beta required | Satisfactory |